Literature DB >> 2307462

An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene.

S Visvikis1, L Chan, G Siest, P Drouin, E Boerwinkle.   

Abstract

In this communication we report the genetic properties of an insertion/deletion polymorphism in the signal peptide of the human apolipoprotein B (apo b) gene. There are two alleles of the apo B signal peptide; one codes for a peptide 27 amino acids in length and the other a peptide only 24 amino acids in length. Using the polymerase chain reaction the difference of nine nucleotides between the two alleles is readily detectable after electrophoresis of the amplification products. The relative frequencies of the Ins and Del alleles are 0.655 and 0.345, respectively. The apo B signal peptide genotypes are transmitted in a manner consistent with an autosomal codominant mode of inheritance with two alleles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307462     DOI: 10.1007/bf00196239

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Unity in function in the absence of consensus in sequence: role of leader peptides in export.

Authors:  L L Randall; S J Hardy
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

Review 2.  DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis.

Authors:  S E Humphries
Journal:  Atherosclerosis       Date:  1988-08       Impact factor: 5.162

3.  Structure of apolipoprotein B-100 of human low density lipoproteins.

Authors:  C Y Yang; Z W Gu; S A Weng; T W Kim; S H Chen; H J Pownall; P M Sharp; S W Liu; W H Li; A M Gotto
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  DNA sequence of the human apolipoprotein B gene.

Authors:  E H Ludwig; B D Blackhart; V R Pierotti; L Caiati; C Fortier; T Knott; J Scott; R W Mahley; B Levy-Wilson; B J McCarthy
Journal:  DNA       Date:  1987-08

Review 6.  Genetic analysis of protein export in Escherichia coli K12.

Authors:  S A Benson; M N Hall; T J Silhavy
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 7.  The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution.

Authors:  W H Li; M Tanimura; C C Luo; S Datta; L Chan
Journal:  J Lipid Res       Date:  1988-03       Impact factor: 5.922

Review 8.  Apoproteins B and A-I and coronary artery disease in humans.

Authors:  J D Brunzell; A D Sniderman; J J Albers; P O Kwiterovich
Journal:  Arteriosclerosis       Date:  1984 Mar-Apr

9.  Expression of rat renal gamma-glutamyltransferase cDNA in Escherichia coli.

Authors:  C Angele; M Wellman; C Thioudellet; G Guellaen; G Siest
Journal:  Biochem Biophys Res Commun       Date:  1989-05-15       Impact factor: 3.575

10.  A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction.

Authors:  E Boerwinkle; L Chan
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

  10 in total
  9 in total

1.  Study of the sequence tagged site (STS) in the beginning of human apo A4 gene region.

Authors:  P de Temmerman; S Visvikis; E Boerwinkle; G Siest
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

2.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

3.  Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.

Authors:  H H Watzke; A Wallmark; N Hamaguchi; P Giardina; D W Stafford; K A High
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

4.  Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study".

Authors:  S Visvikis; J P Cambou; D Arveiler; A E Evans; H J Parra; D Aguillon; J C Fruchart; G Siest; F Cambien
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

5.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Genetic association of APOB polymorphisms with variation in serum lipid profile among the Kuwait population.

Authors:  Suzanne A Al-Bustan; Majed A Alnaqeeb; Babitha G Annice; Ghada A Ebrahim; Thanaa M Refai
Journal:  Lipids Health Dis       Date:  2014-10-08       Impact factor: 3.876

7.  The APOB insertion/deletion polymorphism (rs17240441) influences postprandial lipaemia in healthy adults.

Authors:  Karani Santhanakrishnan Vimaleswaran; Anne M Minihane; Yue Li; Rosalyn Gill; Julie A Lovegrove; Christine M Williams; Kim G Jackson
Journal:  Nutr Metab (Lond)       Date:  2015-03-08       Impact factor: 4.169

8.  Increased Risk of the APOB rs11279109 Polymorphism for CHD among the Kuwaiti Population.

Authors:  Suzanne A Al-Bustan; Fatma G Ismael; Ahmad Al-Serri; Ibrahim Al-Rashdan
Journal:  Dis Markers       Date:  2017-12-06       Impact factor: 3.434

9.  The Study of rs693 and rs515135 in APOB in People with Familial Hypercholestrolemia.

Authors:  Fatemeh Karami; Iman Salahshourifar; Masoud Houshmand
Journal:  Cell J       Date:  2018-11-18       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.